Analyst Viewpoint
Increase in cases of road accidents and rise in prevalence of infectious disorders are fueling the blood group typing market development.
Blood typing is an indispensable technique for ascertaining an individual's blood characteristics. Surge in trauma cases needing blood transfusions and growth in demand for grouping of blood during pregnancy are boosting the blood group typing industry demand.
Key players are concentrating on creating new products and solutions for molecular blood group typing analysis. They are also offering products that facilitate effective management of the workload associated with blood testing.
Blood typing is an indispensable technique for identifying an individual's blood characteristics to ensure the safety of blood donation and transfusion procedures. Blood group determination helps in understating a person's blood group and determining the presence of Rh factor in red blood cells.
ABO and Rh blood typing procedures are used to determine an individual's blood type, which is essential for safe blood transfusions. The presence or lack of specific proteins on red blood cells-known as antigens that shape a person's blood group-determines the blood type, which is inherited from their parents.
Four main blood types may be distinguished using the ABO blood typing system: Type A, Type B, Type AB, and Type O. Every blood type is important since it affects compatibility for blood transfusions and advances the knowledge of each person's physiological makeup.
| Attribute | Detail |
|---|---|
| Drivers |
|
Blood group typing is performed to safely give or receive blood, additionally, blood transfusion is also done to check the presence of Rh factor on the surface of red blood cells. Blood typing products are in high demand due to the increase in traffic accidents.
In October 2021, the German Federal Statistics Office (Destatis) reported that 5,131 persons in Germany lost their lives in traffic accidents in 2020. Furthermore, a study published by the World Health Organization in 2020 stated that nearly 1.5 million people die each year due to road traffic injuries.
Growth in demand for blood group typing in prenatal testing and increase in use of blood group typing in forensic sciences are contributing to the blood group typing market growth.
Pathogens that enter the body, proliferate, and have the potential to cause an infection include bacteria, viruses, fungi, and parasites. Blood group typing is frequently used to check for a particular antibody produced by infectious agents, which helps doctors treat infectious diseases and stop patients from getting sicker and spreading the disease to other people.
The World Health Organization (WHO), in October 2022, stated that roughly 1.6 million people worldwide died from tuberculosis in 2021 (including 187,000 people with HIV).
Furthermore, according to the same source, the prevalence of anemia in children is 48.2% in 2021 and 12.8% in adults. This number is predicted to increase globally in the years to come.As a result, growth in prevalence of blood disorders is propelling the blood group typing market expansion.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
North America held the largest market share in 2022, according to the latest blood group typing market analysis. Increase in number of road accidents, rise in prevalence of chronic diseases, and surge in demand for blood transfusion are fueling the market dynamics of the region.
In 2022, the Association for Safe International Road Travel stated that the U.S. is one of the busiest countries in terms of road traffic with nearly 284 million vehicles in operation as of the third quarter of 2021. As of 2020, there were about 228.7 million drivers with valid driver's licenses.
Heavy road traffic is contributing to the rise in traffic accidents. Approximately 12.15 million vehicles were engaged in crashes in the U.S. as of September 2020, with passenger automobiles accounting for more than half of the total. Thus, increase in traffic fatalities and collisions is bolstering the blood group typing market share.
The global blood group typing landscape is highly competitive, with several opportunities for expansion and innovation. Companies operating in the blood group typing industry are adopting various strategies, such as mergers and acquisitions and new product development, to support medical research and improve patient care.
In February 2022, InTec, an IVD company specializing in infectious disease diagnostics with a focus on screening at the point of care, announced the availability of a newly redesigned ABO & RhD Blood Grouping Kit (Solid-phase method) for blood typing and screening.
Grifols, S.A., Bio-Rad Laboratories, Inc., Merck KGaA, Ortho Clinical Diagnostics, AliveDX, ABG Health Care GmbH, Immucor, Inc., Danaher Corporation, Agena Bioscience, Inc., Rapid Labs Ltd., and Novacyt Group are some of the key players in the global blood group typing market.
Each of these companies has been profiled in the blood group typing market report based on parameters such as company overview, business strategies, financial overview, business segments, product portfolio, and recent developments.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 2.6 Bn |
| Market Forecast (Value) in 2031 | US$ 5.5 Bn |
| Growth Rate (CAGR) | 8.8% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Tons | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 2.6 Bn in 2022
It is projected to grow at a CAGR of 8.8% during the forecast period
Increase in cases of road accidents and rise in prevalence of infectious disorders
North America was the leading region in 2022
Grifols, S.A., Bio-Rad Laboratories, Inc., Merck KGaA, Ortho Clinical Diagnostics, AliveDX, ABG Health Care GmbH, Immucor, Inc., Danaher Corporation, Agena Bioscience, Inc., Rapid Labs Ltd., and Novacyt Group
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Blood Group Typing Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Blood Group Typing Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Blood Group Typing Market Analysis and Forecast, by Product
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Instruments
6.3.1.1. Automated
6.3.1.2. Semi-automated
6.3.1.3. Manual
6.3.2. Consumables
6.3.2.1. Reagents
6.3.2.2. Test Kits
6.3.2.3. Antisera
6.3.2.4. Others
6.3.3. Services
6.4. Market Attractiveness, by Product
7. Global Blood Group Typing Market Analysis and Forecast, by Technique
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technique, 2017–2031
7.3.1. PCR-based
7.3.2. Microarray-based
7.3.3. Assay-based
7.3.4. Massively Parallel
7.3.5. 7.4 Market Attractiveness, by Technique
8. Global Blood Group Typing Market Analysis and Forecast, by Test
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Test, 2017–2031
8.3.1. Antibody Screening
8.3.2. HLA Typing
8.3.3. ABO Matching Test
8.3.4. Cross Matching Test
8.3.5. Antigen Typing
8.4. Market Attractiveness, by Test
9. Global Blood Group Typing Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Clinical Laboratories
9.3.3. Blood Banks
9.3.4. Others
9.4. Market Attractiveness, by End-user
10. Global Blood Group Typing Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Blood Group Typing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Instruments
11.2.1.1. Automated
11.2.1.2. Semi-automated
11.2.1.3. Manual
11.2.2. Consumables
11.2.2.1. Reagents
11.2.2.2. Test Kits
11.2.2.3. Antisera
11.2.2.4. Others
11.2.3. Services
11.3. Market Attractiveness, by Product
11.4. Market Value Forecast, by Technique, 2017–2031
11.4.1. PCR-based
11.4.2. Microarray-based
11.4.3. Assay-based
11.4.4. Massively Parallel
11.5. Market Attractiveness, by Technique
11.6. Market Value Forecast, by Test, 2017–2031
11.6.1. Antibody Screening
11.6.2. HLA Typing
11.6.3. ABO Matching Test
11.6.4. Cross Matching Test
11.6.5. Antigen Typing
11.7. Market Attractiveness, by Test
11.8. Market Value Forecast, by End-user, 2017–2031
11.8.1. Hospitals
11.8.2. Clinical Laboratories
11.8.3. Blood Banks
11.8.4. Others
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2017–2031
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Product
11.11.2. By Technique
11.11.3. By Test
11.11.4. By End-user
11.11.5. By Country
12. Europe Blood Group Typing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Instruments
12.2.1.1. Automated
12.2.1.2. Semi-automated
12.2.1.3. Manual
12.2.2. Consumables
12.2.2.1. Reagents
12.2.2.2. Test Kits
12.2.2.3. Antisera
12.2.2.4. Others
12.2.3. Services
12.3. Market Attractiveness, by Product
12.4. Market Value Forecast, by Technique, 2017–2031
12.4.1. PCR-based
12.4.2. Microarray-based
12.4.3. Assay-based
12.4.4. Massively Parallel
12.5. Market Attractiveness, by Technique
12.6. Market Value Forecast, by Test, 2017–2031
12.6.1. Antibody Screening
12.6.2. HLA Typing
12.6.3. ABO Matching Test
12.6.4. Cross Matching Test
12.6.5. Antigen Typing
12.7. Market Attractiveness, by Test
12.8. Market Value Forecast, by End-user, 2017–2031
12.8.1. Hospitals
12.8.2. Clinical Laboratories
12.8.3. Blood Banks
12.8.4. Others
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2017–2031
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Product
12.11.2. By Technique
12.11.3. By Test
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Blood Group Typing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Instruments
13.2.1.1. Automated
13.2.1.2. Semi-automated
13.2.1.3. Manual
13.2.2. Consumables
13.2.2.1. Reagents
13.2.2.2. Test Kits
13.2.2.3. Antisera
13.2.2.4. Others
13.2.3. Services
13.3. Market Attractiveness, by Product
13.4. Market Value Forecast, by Technique, 2017–2031
13.4.1. PCR-based
13.4.2. Microarray-based
13.4.3. Assay-based
13.4.4. Massively Parallel
13.5. Market Attractiveness, by Technique
13.6. Market Value Forecast, by Test, 2017–2031
13.6.1. Antibody Screening
13.6.2. HLA Typing
13.6.3. ABO Matching Test
13.6.4. Cross Matching Test
13.6.5. Antigen Typing
13.7. Market Attractiveness, by Test
13.8. Market Value Forecast, by End-user, 2017–2031
13.8.1. Hospitals
13.8.2. Clinical Laboratories
13.8.3. Blood Banks
13.8.4. Others
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2017–2031
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Product
13.11.2. By Technique
13.11.3. By Test
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Blood Group Typing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Instruments
14.2.1.1. Automated
14.2.1.2. Semi-automated
14.2.1.3. Manual
14.2.2. Consumables
14.2.2.1. Reagents
14.2.2.2. Test Kits
14.2.2.3. Antisera
14.2.2.4. Others
14.2.3. Services
14.3. Market Attractiveness, by Product
14.4. Market Value Forecast, by Technique, 2017–2031
14.4.1. PCR-based
14.4.2. Microarray-based
14.4.3. Assay-based
14.4.4. Massively Parallel
14.5. Market Attractiveness, by Technique
14.6. Market Value Forecast, by Test, 2017–2031
14.6.1. Antibody Screening
14.6.2. HLA Typing
14.6.3. ABO Matching Test
14.6.4. Cross Matching Test
14.6.5. Antigen Typing
14.7. Market Attractiveness, by Test
14.8. Market Value Forecast, by End-user, 2017–2031
14.8.1. Hospitals
14.8.2. Clinical Laboratories
14.8.3. Blood Banks
14.8.4. Others
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2017–2031
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Product
14.11.2. By Technique
14.11.3. By Test
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Blood Group Typing Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product, 2017–2031
15.2.1. Instruments
15.2.1.1. Automated
15.2.1.2. Semi-automated
15.2.1.3. Manual
15.2.2. Consumables
15.2.2.1. Reagents
15.2.2.2. Test Kits
15.2.2.3. Antisera
15.2.2.4. Others
15.2.3. Services
15.3. Market Attractiveness, by Product
15.4. Market Value Forecast, by Technique, 2017–2031
15.4.1. PCR-based
15.4.2. Microarray-based
15.4.3. Assay-based
15.4.4. Massively Parallel
15.5. Market Attractiveness, by Technique
15.6. Market Value Forecast, by Test, 2017–2031
15.6.1. Antibody Screening
15.6.2. HLA Typing
15.6.3. ABO Matching Test
15.6.4. Cross Matching Test
15.6.5. Antigen Typing
15.7. Market Attractiveness, by Test
15.8. Market Value Forecast, by End-user, 2017–2031
15.8.1. Hospitals
15.8.2. Clinical Laboratories
15.8.3. Blood Banks
15.8.4. Others
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2017–2031
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Product
15.11.2. By Technique
15.11.3. By Test
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Grifols, S.A.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Bio-Rad Laboratories, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Merck KGaA
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Ortho Clinical Diagnostics
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. AliveDx
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. ABG Health Care GmbH
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Immucor, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Danaher Corporation
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Agena Bioscience, Inc.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Rapid Labs Ltd.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Novacyt Group
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
List of Tables
Table 01: Global Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 03: Global Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017–2031
Table 05: Global Blood Group Typing Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Blood Group Typing Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 08: North America Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 09: North America Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017–2031
Table 10: North America Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 11: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 13: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 14: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017–2031
Table 15: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 18: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 19: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017–2031
Table 20: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 23: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 24: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017–2031
Table 25: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 26: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 27: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 28: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 29: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017–2031
Table 30: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Blood Group Typing Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031
Figure 02: Global Blood Group Typing Market Revenue (US$ Mn), by Product, 2022
Figure 03: Global Blood Group Typing Market Value Share, by Product, 2022
Figure 04: Global Blood Group Typing Market Revenue (US$ Mn), by Technique, 2022
Figure 05: Global Blood Group Typing Market Value Share, by Technique, 2022
Figure 06: Global Blood Group Typing Market Revenue (US$ Mn), by Test, 2022
Figure 07: Global Blood Group Typing Market Value Share, by Test, 2022
Figure 08: Global Blood Group Typing Market Revenue (US$ Mn), by End-user, 2022
Figure 09: Global Blood Group Typing Market Value Share, by End-user, 2022
Figure 10: Global Blood Group Typing Market Value Share, by Region, 2022
Figure 11: Global Blood Group Typing Market Value (US$ Mn) Forecast, 2017–2031
Figure 12: Global Blood Group Typing Market Value Share Analysis, by Product, 2022–2031
Figure 13: Global Blood Group Typing Market Attractiveness Analysis, by Product, 2023–2031
Figure 14: Global Blood Group Typing Market Value Share Analysis, by Technique, 2022–2031
Figure 15: Global Blood Group Typing Market Attractiveness Analysis, by Technique, 2023–2031
Figure 16: Global Blood Group Typing Market Value Share Analysis, by Test, 2022–2031
Figure 17: Global Blood Group Typing Market Attractiveness Analysis, by Test, 2023–2031
Figure 18: Global Blood Group Typing Market Revenue (US$ Mn), by End-user, 2022
Figure 19: Global Blood Group Typing Market Value Share, by End-user, 2022
Figure 20: Global Blood Group Typing Market Value Share Analysis, by Region, 2022–2031
Figure 21: Global Blood Group Typing Market Attractiveness Analysis, by Region, 2023–2031
Figure 22: North America Blood Group Typing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 23: North America Blood Group Typing Market Attractiveness Analysis, by Country, 2023–2031
Figure 24: North America Blood Group Typing Market Value Share Analysis, by Country, 2022–2031
Figure 25: North America Blood Group Typing Market Value Share Analysis, by Product, 2022–2031
Figure 26: North America Blood Group Typing Market Value Share Analysis, by Technique, 2022–2031
Figure 27: North America Blood Group Typing Market Value Share Analysis, by Test, 2022–2031
Figure 28: North America Blood Group Typing Market Value Share Analysis, by End-user, 2022–2031
Figure 29: North America Blood Group Typing Market Value Share Analysis, by End-user, 2022–2031
Figure 30: North America Blood Group Typing Market Attractiveness Analysis, by Product, 2023–2031
Figure 31: North America Blood Group Typing Market Attractiveness Analysis, by Technique, 2023–2031
Figure 32: North America Blood Group Typing Market Attractiveness Analysis, by Test, 2023–2031
Figure 33: North America Blood Group Typing Market Attractiveness Analysis, by End-user, 2023–2031
Figure 34: Europe Blood Group Typing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 35: Europe Blood Group Typing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 36: Europe Blood Group Typing Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 37: Europe Blood Group Typing Market Value Share Analysis, by Product, 2022–2031
Figure 38: Europe Blood Group Typing Market Value Share Analysis, by Technique, 2022–2031
Figure 39: Europe Blood Group Typing Market Value Share Analysis, by Test, 2022–2031
Figure 40: Europe Blood Group Typing Market Value Share Analysis, by End-user, 2022–2031
Figure 41: Europe Blood Group Typing Market Value Share Analysis, by End-user, 2022–2031
Figure 42: Europe Blood Group Typing Market Attractiveness Analysis, by Product, 2023–2031
Figure 43: Europe Blood Group Typing Market Attractiveness Analysis, by Technique, 2023–2031
Figure 44: Europe Blood Group Typing Market Attractiveness Analysis, by Test, 2023–2031
Figure 45: Europe Blood Group Typing Market Attractiveness Analysis, by End-user, 2023–2031
Figure 46: Asia Pacific Blood Group Typing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 47: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 48: Asia Pacific Blood Group Typing Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 50: Asia Pacific Blood Group Typing Market Value Share Analysis, by Product, 2022–2031
Figure 51: Asia Pacific Blood Group Typing Market Value Share Analysis, by Technique, 2022–2031
Figure 52: Asia Pacific Blood Group Typing Market Value Share Analysis, by Test, 2022–2031
Figure 53: Asia Pacific Blood Group Typing Market Value Share Analysis, by End-user, 2022–2031
Figure 54: Asia Pacific Blood Group Typing Market Value Share Analysis, by End-user, 2022–2031
Figure 55: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by Product, 2023–2031
Figure 56: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by Technique, 2023–2031
Figure 57: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by Test, 2023–2031
Figure 68: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by End-user, 2023–2031
Figure 59: Latin America Blood Group Typing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 60: Latin America Blood Group Typing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 61: Latin America Blood Group Typing Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 62: Latin America Blood Group Typing Market Value Share Analysis, by Product, 2022–2031
Figure 63: Latin America Blood Group Typing Market Value Share Analysis, by Technique, 2022–2031
Figure 64: Latin America Blood Group Typing Market Value Share Analysis, by Test, 2022–2031
Figure 65: Latin America Blood Group Typing Market Value Share Analysis, by End-user, 2022–2031
Figure 66: Latin America Blood Group Typing Market Value Share Analysis, by End-user, 2022–2031
Figure 67: Latin America Blood Group Typing Market Attractiveness Analysis, by Product, 2023–2031
Figure 68: Latin America Blood Group Typing Market Attractiveness Analysis, by Technique, 2023–2031
Figure 69: Latin America Blood Group Typing Market Attractiveness Analysis, by Test, 2023–2031
Figure 70: Latin America Blood Group Typing Market Attractiveness Analysis, by End-user, 2023–2031
Figure 71: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 72: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 73: Middle East & Africa Blood Group Typing Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 74: Middle East & Africa Blood Group Typing Market Value Share Analysis, by Product, 2022–2031
Figure 75: Middle East & Africa Blood Group Typing Market Value Share Analysis, by Technique, 2022–2031
Figure 76: Middle East & Africa Blood Group Typing Market Value Share Analysis, by Test, 2022–2031
Figure 77: Middle East & Africa Blood Group Typing Market Value Share Analysis, by End-user, 2022–2031
Figure 78: Middle East & Africa Blood Group Typing Market Value Share Analysis, by End-user, 2022–2031
Figure 79: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by Product, 2023–2031
Figure 80: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by Technique, 2023–2031
Figure 81: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by Test, 2023–2031
Figure 82: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Blood Group Typing Market
